Develops molecular profiling solutions for cancer patients.
Jun 2026Revenue $990M/yrExpenses $836M/yr
Reached break-even Nov 2025
Figures by year
When did Caris Life Sciences become profitable?
Its revenue passed its expenses in Nov 2025. In the 12 months to Jun 2026, revenue was $990M and expenses $836M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $812M | $767M | $45.1M |
| Dec 2024 | $412M | $669M | −$257M |
| Dec 2023 | $306M | $626M | −$320M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.